Inspire Medical Systems Inc (INSP) Stock AnalysisINSPInspire Medical Systems Inc

Inspire Medical Systems, Inc. is a medical technology company. The Company focuses on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is neurostimulation technology that provides safe and effective treatment for moderate to severe obstructive sleep apnea. The Company's closed-loop solution continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Inspire Medical Systems Inc (INSP) is a good buy right now due to its current price of $71.11, which is below several analyst price targets indicating potential upside. Notably, Freedom Broker's target of $97 suggests a 36.4% upside from the current price. Additionally, the company reported a gross margin of 86.47% for Q1 2026, indicating strong profitability. However, the forward P/E ratio of 59.17 suggests that the stock may be overvalued if growth does not materialize as expected, representing a key risk.

5 analysts cover INSP: 3 rate it Buy, 2 Hold and 0 Sell. The average price target is 145.31.